baber/WOPTO huggingface dataset:
Patent FI-933589-A0 (FI)
Inventor: REIPUR JOHN
IPC: G01R31/36
Filed: 1993-08-13
Abstract: A rechargeable battery is charged by connecting the terminals of the battery to an electrical power source. In order to avoid overcharging and undue temperature increase in the battery cell, the course of a least one charging parameter, such as the increase rate of the voltage, is surveyed during at least part of the process of charging the battery. This charging parameter surveyed is compared with a number of reference parameter courses representing idealistic or desireable processes of charging the battery for different starting states of charge of the battery. Such comparisons may for example be made by means of a microprocessor, which may also select the reference course with a starting state of charge similar to the actual starting state of charge of the battery. Thereafter the process of charging the battery may be controlled so as to approximate the course of said charging parameter to the selected reference course. The charging voltage may be limited to a maximum value (Vmax). When such value has been reached the charging process may be terminated after a certain predetermined time period being one of the reference values. <IMAGE>
Patent FI-934508-A0 (FI)
Inventor: GRAVES FREDERIC A
IPC: C07C403/24
Filed: 1993-10-12
Abstract: A carotenoid-enriched fraction is extracted from natural sources, such as carrots, by (i) separating the carotenoid-containing natural source into a carotenoid-containing liquid fraction and a pulp fraction, (ii) adding a carotenoid precipitation agent including calcium chloride, calcium hydroxide, calcium lactate or calcium gluconate to the liquid fraction to form a carotenoid-enriched solid precipitate, and (iii) separating the carotenoid-enriched solid precipitate from the carotenoid-depleted liquid portion.
Patent FI-945647-A0 (FI)
Inventor: SEVERIN JANE E
IPC: B65D75/38
Filed: 1994-11-30
Abstract: A dispensing package assembly useful for dispensing a predetermined amount of a fluent material comprises a relatively stiff base sheet, a blister overlay appended to the overlay and a dispenser pouch housed within the confines of the overlay and the sheet. The blister overlay having a main cavity and a secondary cavity includes a dispenser depression, preferably in the shape of a thumb indention, which protrudes downward into the main cavity. A shearing depression extending laterally through the secondary cavity defines an area of reduced depth within the secondary cavity. The main body of the pouch is located within the overlay main cavity having a dispensing channel or passageway extending therefrom beneath the shearing depression and into the secondary cavity.
Patent FI-963660-A0 (FI)
Inventor: ROSENGREN LARS
IPC: F21V5/02
Filed: 1996-09-16
Abstract: The present invention is for a lighting device by which a controlled light pattern is obtained from a specific light source. The device comprises a light source which emits several parallel light beams. There is one prism (3) for each light beam (8), which passes through the lighting device. All of the prisms are integrated parts of a common disc. Preferrably the light source comprises several light emitting diodes (1) each emitting one light beam. The prisms are suitably made as straight, circular cylinders, at least those parts thereof which protrude from the common disc. The oblique surface may be freely varied at both its angle at the axis of the cylinder and direction whereby the direction of the corresponding light beam may be controlled.
Patent FI-964765-A0 (FI)
Inventor: OCIECZEK GRZEGORZ
IPC: G21C17/108
Filed: 1996-11-29
Abstract: PCT No. PCT/SE95/00634 Sec. 371 Date Feb. 27, 1997 Sec. 102(e) Date Feb. 27, 1997 PCT Filed Jun. 2, 1995 PCT Pub. No. WO95/34077 PCT Pub. Date Dec. 14, 1995A method of monitoring neutron flex detectors in a nuclear reactor in a neural network is provided. The network comprises an input layer which receives a number of input signals corresponding to values of a measured signal at different times and an output layer which is adapted to deliver a number of state signals. The network is taught to identify a number of different trends of the measured signal such that the state signals indicate the trends, by supplying the network with a plurality of input signals which have known state signals. The network is then supplied with input signals which correspond to values of a measured signal taken at different times from a supervised detector. Also, input signals corresponding to values of measured signals taken at different times from a reference detector are supplied to the network. Next, state signals for the supervised detector and for the reference detectors are calculated and whether the supervised detector is defective is determined based on the state signals.
Patent IL-63975-A0 (IL)
Title: Transferable enamel sheet,method and apparatus for its fabrication
IPC: B44C1/17
Filed: 1981-09-28
Abstract: A transferable enamel sheet and the process for producing it is disclosed, which consists of a carrier film, a release layer applied thereon, a paint or enamel layer and an adhesive layer whereby a neutralization layer of wax-type consistency, preferably carnuaba wax is applied to the release layer which is of the dimethyl-siloxane type (silicone). It is possible to preform two types of transferable enamel sheets. One of them is characterized by the adhesive layer between the neutralization layer and the paint or enamel layer. In this case the enamel paint itself is used as a removal coating, which can immediately be adhered to the surface to be touched up or painted. The other type is characterized by a buffer layer, preferably acrylic resin coated on the neutralization layer and by sharp defined enamel-characters being printed on the buffer layer with an adhesive layer on the outer side to transfer the characters to any surface.
Patent IL-79254-A0 (IL)
Title: Compositions for preventing graft rejection
IPC: A61P37/00
Filed: 1986-06-26
Abstract: The invention relates to means for preventing or for delaying the rejection of allografts in humans and for the alleviation of and for treating autoimmune diseases in humans. The pharmaceutical compositions which are suitable to attain the above ends ard based on heparin, on N-desulfated, on N-acetylated heparin or other suitable derivatives of heparin. The dosage which is effective is one which is substantially lower than that required for obtaining an anticoagulant effect in mammals. It is generally of the order of about 1 per cent to about 10 per cent of the anti-coagulant effective dosage of such compounds.
Patent IL-98139-A0 (IL)
Title: Use of substituted 1,2,4-triazinediones for combating parasitic protozoa
IPC: A01N43/707
Filed: 1991-05-14
Abstract: The present invention relates to the use of substituted 1,2,4-triazinediones of the general formula (I) 
<IMAGE>
 in which 
 
  R<1> is optionally substituted pyridyl, pyrazinyl or pyrimidinyl, 
  X is O, S, SO, SO2 or -CR<4)<CN)-, 
  R<2> is hydrogen, one or more identical or different radicals from the group comprising hydrogen, halogen, nitro, alkyl, alkoxy, alkylthio, halogenoalkyl, halogenoalkoxy, alkylthio, halogenoalkylthio, 
  R<3> is hydrogen, optionally substituted alkyl, alkenyl, alkynyl, aralkyl, 
  R<4> is hydrogen or alkyl, 
 for controlling parasitic protozoa.
Patent SE-9402213-A0 (SE)
Inventor: HUANG THOMAS B
IPC: G11C8/16
Filed: 1994-06-22
Abstract: --------- – 'SOKANDE _ PiE DESIGN SYSTEMS,INC. 440 Clyde Avenue Mountain View,Californiip. 94043I USAf'—---....-c'•''---zli-1'iv, UPPFINNARE THOMAS B. HUANG 3526 Pinnacle Court San Jose, California 95132 USA BENAMNING METHOD AND APPARATUS FOR CONFIGURING MEMORY CIRCUITS PRIORITET 24 juni 1993 - USA - 08/082,051 AVDELAD/ UTBRUTEN Giltighetsdag Stamansokans nr ------- BILAGOR AVGIFTER -- Beskrivning Patentkrav Sammandrag 4ritn,1 ex Utlandsk text Forteckning Anstikningsavgift Extra kravavgift ITS-granskning Bestallning av diariebevis Totalt -- Overlatelse Fullmakt Prioritetsbevis Oversattn av priorbevis Diariebevis i Check 1 600 kr 1 900 kr kr 20 kr kr x x x - 3 520 kr -._
Patent FI-20070477-A0 (FI)
Inventor: VEHMAA JANNE
IPC: D21C/
Filed: 2007-06-15
Abstract: A method for treating liquid flows at a chemical pulp mill including at least an alkaline cooking process for producing pulp, brown stock treatment with essentially closed liquid cycles, a pulp bleaching plant using ECF-bleaching, a chemical recovery plant comprising a chemical recovery boiler, and effluent purification. Chloride-containing bleaching plant effluents are led to the effluent purification, where they are treated in order to decrease the organic matter content thereof. At least 20% of the purified effluent is returned to a pulp mill process and purified effluent is used in a last washing stage included in brown stock treatment. In the brown stock treatment the liquid flow is passed counter-currently to evaporation, wherefrom it is led for treatment to a recovery boiler process, wherein a separation process for chlorides is arranged for controlling the chloride level of the liquor cycle.
Patent FI-20105170-A0 (FI)
Inventor: PELTOLA ALEKSI
IPC: B01F33/45
Filed: 2010-02-23
Abstract: An air distribution and mixing device is arranged in the vicinity of the bottom of a flotation cell for distributing air to the slurry for forming froth and mixing the slurry in the flotation cell. A rotor part of the air distribution and mixing device has air distribution apertures and is attached to the lower end of a drive shaft extending vertically in the flotation cell. The drive shaft has a hollow interior, which constitutes a flow channel for conducting flotation air to the air distribution holes of the rotor part. An electric motor for rotating the drive shaft is supported by a separate supporting framework, which is on top of the flotation cell. The electric motor is a permanent magnet motor that comprises having a vertical rotor shaft, the lower end of which is in permanent contact directly with the upper end of the drive shaft.
Patent FI-20106311-A0 (FI)
Inventor: TIRRONEN ESKO
IPC: C07C/
Filed: 2010-12-10
Abstract: The present invention relates to a method and an arrangement for recovery of at least one organic acid from a dilute aqueous solution thereof. In this method a complex between said organic acid and an extractant is formed by contacting the solution with a reactive extractant and dissolving the formed complex into said extractant thus forming an extractant phase. The organic acid is removed from the formed complex by esterification using an alcohol.
Patent IL-104861-A0 (IL)
Title: Tape volume partitioning
IPC: G11B20/12
Filed: 1993-02-25
Abstract: A method for formatting a length of magnetic tape into a plurality of partition areas (100,110,118,126,120) to enable data storage in any of these areas and for formatting on the magnetic tape a plurality of spaced system zones (102,114,122), by means of controlling programs of a recording device prompting a host computer system to input the number and spacing of the system zones and the length and number of the partitions to be formatted onto the magnetic tape. The programs also prompts the host computer system to select one of various options (7A,7B,7C) for placing a partitions on the magnetic tape. <IMAGE>
Patent IL-110581-A0 (IL)
Title: Insulin formulation
IPC: A61K33/30
Filed: 1994-08-08
Abstract: The present invention is directed to an insulin formulation comprising a suspension of Ultralente crystals and a total formulation zinc concentration of between about 0.5 milligrams to about 20 milligrams per 100 units of insulin. Greater than fifty percent of the total zinc in the formulation resides in the soluble fraction, rather than in complex with the insulin. This insulin formulation generally has a pH from between about 6.0 to about 7.4. In addition, the insulin formulation of the present invention does not contain other proteins like protamine. This zinc-modified formulation displays characteristics of a very long lasting human insulin product.
Patent IL-114343-A0 (IL)
Title: Use of IGF-I in the prevention of diabetes
IPC: A61P3/10
Filed: 1995-06-26
Abstract: IGF-I or an analogue thereof is administered to delay the clinical onset of diabetes, to reduce the occurrence of beta cell destruction in a subject having a high risk of developing diabetes, to provide a regulating effect on spleen T cells in a subject having a high risk of developing diabetes, or to reduce the likelihood of the occurrence of clinical diabetes in a subject having a high risk of developing diabetes.
Patent IL-120405-A0 (IL)
Title: A process for the preparation of a colloidal suspension of a zeolite zeolites produced thereby and uses thereof
IPC: B01J37/025
Filed: 1996-07-09
Abstract: Low temperature hydrothermal treatment of an LTL zeolite-producing mixture produces a colloidal suspension of the zeolite; the suspension may be used as seeds in Al- and Ga-LTL zeolite manufacture.
Patent IL-123249-A0 (IL)
Title: Oriented polymeric products
IPC: B29C48/94
Filed: 1996-06-26
Abstract: PCT No. PCT/EP96/02801 Sec. 371 Date Jul. 28, 1998 Sec. 102(e) Date Jul. 28, 1998 PCT Filed Jun. 26, 1996 PCT Pub. No. WO97/10941 PCT Pub. Date Mar. 27, 1997A continuous method of extruding an oriented plastic article of improved strength. A chemically reactive polymer, monomer or other compound is included in the matrix material(s) and a (multilayer) parison is extruded or melt formed having built-in thermoplastic orientation caused by shear or caused by elongational flow. A reaction can be activated in the molten state thereof by additional heat resulting in a cross-linked structure or at least the mobility of the molecules being reduced, resulting in a longer relaxation time which makes the freezing of permanent orientation possible. The soft matrix can be stretched while still hot in the hoop and/or axial direction. Then, the product thus obtain is calibrated and cooled in an oriented state.
Patent IL-129318-A0 (IL)
Title: Use of 1-benzyl-3- (substituted hetaryl)- fused pyrazole derivatives
IPC: C07D409/04
Filed: 1997-10-01
Abstract: The present invention relates to the new use of 1-benzyl-3-(substituted hetaryl)-fused pyrazole derivatives, some of which are known, of the general formula (I)in which R1 to R4 have the meaning indicated in the description, as medicaments, and to new active compounds, in particular to their use as vasodilators, if appropriate in combination with organic nitrates and NO donors and if appropriate in combination with compounds which inhibit the degradation of cGMP.
Patent IL-133206-A0 (IL)
Title: Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
IPC: A61K47/10
Filed: 1998-07-01
Abstract: PCT No. PCT/EP98/04176 Sec. 371 Date Jan. 27, 2000 Sec. 102(e) Date Jan. 27, 2000 PCT Filed Jul. 1, 1998 PCT Pub. No. WO99/01135 PCT Pub. Date Jan. 14, 1999The present invention provides an aqueous pharmaceutical composition comprising 5 to 200 mg/ml of eletriptan hemisulfate and from 0.5 to 2.0% weight/volume of caffeine.
Patent IL-135038-A0 (IL)
Title: Prostate boundary segmentation from 2d and 3d ultrasound images
IPC: G06T5/00
Filed: 2000-03-14
Abstract: A fast semi-automatic prostate contouring method and apparatus using model-based initialization and an efficient Discrete Dynamic Contour (DDC) for boundary refinement. The user initiates the process of the preferred embodiment by identifying four (4) points on the prostate boundary, thereby scaling and shaping a prostate model, and then the final prostate contour is refined with a DDC. The method of the present invention has particular application during the pre-implant planning phase of a brachytherapy procedure. However, this method also has uses in any phase of dose planning in the brachytherapy procedure or any other therapy approach.  <IMAGE>
Patent IL-138690-A0 (IL)
Title: Synthetic endogenous cannabinoids, analogues and uses thereof
IPC: C07C43/178
Filed: 1999-03-30
Abstract: The present invention relates to a compound of the general formula (I) which is a non-hydrolysable analogue of endogenous cannabinoids, which are found to be more potent therapeutic agents as they are more stable, for example, to hydrolytic cleavage in the gastrointestinal tract. The cannabinoid analogues of the invention have a therapeutic value. Therefore, pharmaceutical compositions comprising as active ingredient a therapeutically effective amount of at least one compound of the invention may be prepared. Such compositions may be used as anti-inflammatory, anti-asthmatic, analgetic, hypotensive, antiemetic or anti-spasmodic compositions, and as compositions for treating and/or preventing glaucoma or migraine, or as compositions for relieving symptoms of multiple sclerosis and mood stimulating compositions.
Patent IL-141277-A0 (IL)
Title: Modular doors
IPC: E06B3/70
Filed: 2001-02-05
Abstract: The invention provides a modular door (82) formed from a plurality of inter-linked elements, comprising two end elements (84,86), at least one of which is provided with integral hinge-attachment means (14), and two series of inter-linked panels (52a,52b), a first series forming the inner facing major surface of the door and a second series forming the outer facing major surface of the door, wherein the panels are further provided with connector means along at least one of the major surfaces thereof, the arrangement being such that each of the panels can be installed in its respective series with the connector means facing outwards for the attachment of facing panels thereto, or can be installed in its respective series with the connector means facing inwards for attachment to a reinforcing element inserted between the two series of inter-linked panels and interconnecting the same via the connector means. <IMAGE>
Patent IL-144242-A0 (IL)
Title: Pre-conditioning against cell death
IPC: A61P1/16
Filed: 2000-01-11
Abstract: Apoptosis and/or necrosis related disorders in the mammalian body, namely radiation exposure disorders, chemical exposure and ingestion disorders, neurological disorders and physical trauma disorders, are treated, and their onset is counteracted by pre-conditioning, by extracting from the mammalian body an aliquot of blood, subjecting the extracted aliquot, ex vivo, to an oxidative stressor such as exposure to ozone gas, a temperature stressor, i.e. temperatures above or below body temperatures, and ultraviolet light, and re-injecting the treated blood aliquot into the mammalian body. The treatment has the effect of decreasing apoptosis/necrosis in the body, and of pre-conditioning the body better to withstand subsequently encountered apoptosis-inducing events.
Patent IL-145897-A0 (IL)
Title: Hemofiltration system
IPC: B01D61/32
Filed: 2000-04-28
Abstract: A multipurpose hemofiltration system (10) and method are disclosed for the removal of fluid and/or soluble waste from the blood of a patient. The system (10) continuously monitors the flow rates of drained fluid, blood, and infusate. When necessary, the pumping rates of the infusate, drained fluid and blood are adjusted to remove a preselected amount of fluid from the blood in a preselected time period. A supervisory controller (160) can monitor patient parameters, such as heart rate (120) and blood pressure (130), and adjust the pumping rates accordingly. The supervisory controller (160) uses fuzzy logic to make expert decisions, based upon a set of supervisory rules, to control each pumping rate to achieve a desired flow rate and to respond to fault conditions. An adaptive controller (162) corrects temporal variations in the flow rate based upon an adaptive law and a control law.
Patent IL-151757-A0 (IL)
Title: Glucopyranosyloxy benzylbenzene derivatives, medicinal compounds containing the same and intermediates for the preparation of the derivatives
IPC: A61P3/04
Filed: 2001-03-15
Abstract: The present invention relates to glucopyranosyloxybenzylbenzene derivatives represented by the general formula: <CHEM> wherein R<1> represents a hydrogen atom or a hydroxy( lower alkyl) group; and R<2> represents a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a hydroxy(lower alkyl) group, a hydroxy(lower alkoxy) group, a hydroxy(lower alkylthio) group etc., and salts thereof, which have an excellent inhibitory activity in human SGLT2 and are useful as agents for the prevention or treatment of diabetes, obesity etc., and intermediates thereof.
Patent IL-156375-A0 (IL)
Title: Method for in vitro culture of ovarian follicles
IPC: C12Q1/02
Filed: 2001-12-11
Abstract: The present invention is related to a method for in vitro culture of mammalian ovarian follicles, comprising the following subsequent steps:     providing a suitable container for the in vitro culture, selecting a follicle from an ovary of a mammal, said follicle comprising at least a theca or pre-theca cell, a granulosa cell and an oocyte, an optional first culture step using an attachment prohibiting first medium free from oil, a second culture step using an attachment promoting second medium free from oil arranged to, and   the retrieval of the matured follicle.   <IMAGE>
Patent IL-159191-A0 (IL)
Title: A building panel and panel crimping machine
IPC: E04B7/10
Filed: 2002-06-18
Abstract: This invention relates to a panel crimping machine including a pair of crimping rollers (1102,1104) offset from one another and located within the panel crimping machine such that when a panel enters the panel crimping machine the curved central portion of the panel (900) passes between the crimping rollers. 
The pair of crimping rollers comprise a male crimping roller (1102) comprising a hub and a plurality of male crimping blades (1110) extending radially from the hub, each of the male crimping blades having a convex profile, and a female crimping roller (1104) comprising a hub and a plurality of female crimping blades (1112) extending radially from the hub, each of the female crimping blades having a concave profile complimentary to the convex profile of the male crimping blades. 
The machine further comprises means for driving the pair of crimping rollers such that the crimping rollers rotate, thereby causing the male crimping blades and the female crimping blades to alternately intersect and crimp the curved central portion of the panel.
Patent IL-172158-A0 (IL)
Title: Method for detecting trace explosives using photoluminescence
IPC: G01N21/64
Filed: 2005-11-24
Abstract: A method for detecting trace explosives which includes obtaining a sample believed to contain explosives residue and contacting the sample and a carrier container containing the sample with a reagent. The sample and the carrier is illuminated by an appropriate laser or other light source while it is contained within a light tight box. The sample and the carrier is observed during the elimination to determine photoluminescence of the sample as an indication that it contains trace explosives. The reagent may be an alkaline containing substance, a lanthanide complex, a lanthanide complex containing sensitizing ligands or nanocrystals.